MathematicalModel For Finding ACPM Of MTBF Projection In Plasma Vasopressin And Response To Treatment In Primary Nocturnal Enuresis

In this paper, we apply the results on both the model AMSAA Crow projection model and Reliability growth potential effects of vasopressin to examine the relation between nocturnal vasopressin release and response to treatment with the vasopressin analogue 1-desamino-8-D-Arginine Vasopressin (DDAVP) in children with primary mono symptomatic nocturnal enuresis. In this application the ability to respond to DDAVP is related to endogenous AVP production and is influenced by neuronal patterning in early infancy. The result concludes that ACPM of MTBF projection is estimated of the system failure intensity.ρ GP is the growth potential of Mean time between failure of AVP release according to the result in the estimated growth potential failure intensity , the estimate of the system MTBF growth potential. Thus the ACPM Projection for the system failure intensity, based onβ , the corresponding MTBF Projection value is nearly equal to the Projected system failure intensity based onβ m , the corresponding MTBF Projection values.